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Abstract
Background: ENU-mutagenesis is a powerful technique to identify genes regulating mammalian
development. To functionally annotate the distal region of mouse chromosome 4, we performed
an ENU-mutagenesis screen using a balancer chromosome targeted to this region of the genome.
Results: We isolated 11 lethal lines that map to the region of chromosome 4 between D4Mit117
and D4Mit281. These lines form 10 complementation groups. The majority of lines die during
embryonic development between E5.5 and E12.5 and display defects in gastrulation, cardiac
development, and craniofacial development. One line displayed postnatal lethality and neurological
defects, including ataxia and seizures.
Conclusion: These eleven mutants allow us to query gene function within the distal region of
mouse chromosome 4 and demonstrate that new mouse models of mammalian developmental
defects can easily and quickly be generated and mapped with the use of ENU-mutagenesis in
combination with balancer chromosomes. The low number of mutations isolated in this screen
compared with other balancer chromosome screens indicates that the functions of genes in
different regions of the genome vary widely.
Background
N-ethyl-N-nitrosourea (ENU) mutagenesis is a powerful
tool in the mouse and can be used to generate point muta-
tions in spermatogonial cells. Many ENU screens have
been conducted to isolate developmental mutations in a
small region of the genome or to isolate mutants with par-
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function in targeted regions of the genome, we have taken
an approach to mutagenesis screening that does not bias
the results towards a particular developmental stage or
defect. We have previously conducted forward genetic
screens in combination with genetically engineered bal-
ancer chromosomes tagged with coat color markers for
visual genotyping [2,3]. We previously reported 78 reces-
sive novel lethal mutants that die before three weeks of
age (59 were mapped to chromosome 11 and 19 were
mapped to chromosome 4) [4,5]. These chromosomes
were targeted because of their high conservation with
human chromosomes 17 and 1, respectively. In this study,
we examine a second region of the distal portion of mouse
chromosome 4, located between 96 and 130 Mb. This
region is highly conserved with human chromosome 1. By
targeting a region with high human conservation, we
sought to functionally annotate the genes in the region,
and create mouse models of human diseases that map to
the corresponding region of human chromosome 1.
Results
Chromosome 4 balancer screen
We report here the use of a mouse chromosome 4 bal-
ancer in an ENU-mutagenesis screen. In this screen, we
use an inversion between the simple sequence length
repeat markers D4Mit117 and D4Mit281 that spans a 33
Mb interval containing 470 genes (Ensembl v51) (Fig 1A,
C). This screen will be referred to as the chromosome 4
(117–281) screen, named for its flanking microsatellite
markers. The balancer interval is highly conserved with 2
distinct regions of human chromosome 1 (60.2Mb-
67.3Mb and 188Mb-215Mb) (Fig. 1C). The total genomic
length of these two homologous regions, 33Mb, equals
that of the balancer region.
Unlike classic Drosophila balancer chromosomes, the end-
points of the chromosome 4 (117–281) balancer region
do not disrupt any essential genes [6]. Therefore, homozy-
gosity of the balancer is not lethal. The endpoints of the
balancer are tagged with the coat color markers Tyrosinase
(Tyr) and K14-Agouti (K14-Ag). Two copies of the balancer
give a dark brown coat color and one copy gives a light
brown coat color (Fig. 1F, G) [2]. In the three generation
breeding scheme used to isolate recessive mutants, male
C57BL/6Brd Tyr-/- (B6-albino) are injected with ENU (Fig
1B). B6-albino mice are easily distinguished by coat color
from animals carrying the balancer. After injection, fertile
B6-albino ENU males are mated to females that are
homozygous for the balancer, which is carried on a
C57BL/6J Tyr-/- genetic background. The G1 progeny
from this cross are mated again to homozygous balancer
animals to generate G2 animals. Intercrosses of the G2
animals generate homozygous mutant animals in the
third generation of the screen. Mice homozygous for the
potentially mutated chromosome 4 do not carry the bal-
ancer and are therefore albino with a white coat color and
a lack of eye pigment (Fig. 1D–G). The lack of eye pigment
in the homozygous mutants allowed for visual genotyp-
ing of the embryos starting at mid-gestation (E12.5 and
beyond) (Fig. 1D). Embryos that were dissected before
E12.5 were genotyped by the polymorphic simple
sequence length repeat markers D4Mit12 and D4Mit332,
which lie within the balancer region. After birth, coat
color (white, light brown, and dark brown) was used to
genotype the homozygous mutants, heterozygous bal-
ancer mice, and homozygous balancer mice, respectively
(Figure 1F, G). Our ability to genotype throughout devel-
opment and after birth by eye pigment, coat color, or PCR
provided a great advantage over traditional mutagenesis
screens in determining if phenotypes segregated to the
balancer region.
Five hundred and thirty pedigrees were screened for muta-
tions over the chromosome 4 (117–281) balancer. Sev-
enty-five mutant lines were initially identified by the
observation of two or more offspring presenting with the
same mutant phenotype. The mutant lines displayed a
wide range of phenotypes, including lethality, failure to
thrive, neurological defects, skeletal defects, craniofacial
abnormalities, blood cell defects, urogenital defects, and
abnormalities of the skin, coat, and eyes. Only eleven
lines segregated in trans to the 4 (117–281) balancer and
all were lethal. The other 64 mutations are located in chro-
mosome regions outside of the 33Mb balancer region of
chromosome 4. Each of these mutant lines are available to
the scientific community, and can by found by their MGI
Accession number shown in Table 1http://www.informat
ics.jax.org/.
Eleven lethal lines isolated
Eleven lethal lines named l4Jus19, and l4Jus22 to l4Jus31
segregated in trans to the 4 (117–281) balancer, and there-
fore, map to the region (Table 1). A lethal mutant line was
detected and mapped simultaneously to the region if 30
homozygous or heterozygous balancer mice were
observed at weaning with no homozygous mutant litter-
mates. Additional matings confirmed the heritable nature
of the mutation as well as the segregation of the mutation
to the balancer region (Table 1). The eleven lines fell into
ten complementation groups. The two lines l4Jus19 and
l4Jus26 fail to complement and are likely different mutant
alleles of the same gene (Table 2). In the cross between
l4Jus19 and l4Jus26, 31 mice carrying one or two copies of
the balancer were found at weaning while no animals
lacking the balancer, and therefore having an albino coat
color, were observed (Expected = 8, p < 0.001).
The genotypes of all animals that were alive at weaning are
shown for the eleven lines in Table 1. For all of the lines,Page 2 of 12
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Chromosome 4 (117–281) Balancer ScreenFigure 1
Chromosome 4 (117–281) Balancer Screen. A. The balancer regions used in this screen (red) and in a previously pub-
lished screen (dark gray) are shown. Genotyping microsatellite markers are shown in red. Base pairs refer to Ensembl v51. B. 
The mating scheme used for the chromosome 4 (117–281) balancer screen is shown. Red or "m" indicates a new ENU-induced 
lesion and black indicates the balancer chromosome. Males are depicted with squares and females are depicted with circles. 
Diamonds represent either sex. C. The mouse chromosome 4 balancer is depicted with a red line. Microsyntenies, represent-
ing 50–800 bp fragments and averaging 100–200 bp, were blasted and aligned to full-length human chromosome 1, depicted 
with a blue line. Light blue lines connect each hit of microsynteny conservation between the two chromosomes. Two large 
areas of linkage conservation are evident on the human chromosome. D-G. Homozygous mutants, heterozygous balancer ani-
mals, and homozygous balancer animals are all easily distinguished by coat color and the presence or absence of eye pigment at 
several different stages. A homozygous lethal embryo (no eye pigment) is pictured at E15.5 (D, right) next to a control litter-
mate (D, left). An albino mutant pup lacking eye pigment is easily distinguished from control littermates at P3 (E, far right). 
Homozygous mutants (white, no eye pigment), heterozygous balancer animals (light brown), and homozygous balancer animals 
(dark brown) are shown at both the P11 (F) and adult stages (G) and can easily be differentiated by coat color.
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embryonic or postnatal lethality, were observed. For seven
of the lines (l4Jus19, l4Jus22, l4Jus23, l4Jus24, l4Jus26,
l4Jus27, and l4Jus28), no homozygous mutants were ever
observed at birth or weaning, indicating fully-penetrant
embryonic lethality. For three lines (l4Jus25, l4Jus29, and
l4Jus30), a few homozygous mutants were observed at
weaning. It is possible that these weanlings are survivors
of incompletely penetrant phenotypes or that the mutated
gene is outside of but linked to the balancer region, and
that these weanlings are recombinant wild-type mice.
However, we would expect recombinants to be healthy
and of normal size, and these mice were unhealthy and
died soon after weaning, making the first possibility more
likely.
Notably, seventeen small l4Jus31 homozygous mutants
were present out of 139 mice weaned but none survived
to sexual maturity, indicating that this line had a postnatal
time of death (Table 1, 3).
Table 1: Mice from lethal lines produced in the chromosome 4 screen
Line Name MGI Accession # # homozygous 
balancer (dark brown)
# heterozygous 
mutants (light brown)
# homozygous 
mutants (white)
Chi-square 
probability (p)
l4Jus19 MGI:3033989 29 57 0 p < 0.001
l4Jus22 MGI:3038760 40 88 0 p < 0.001
l4Jus23 MGI:3043664 18 56 0 p < 0.001
l4Jus24 MGI:3043665 39 102 0 p < 0.001
l4Jus25 MGI:3046735 46 56 2 p < 0.001
l4Jus26 MGI:3577468 38 83 0 p < 0.001
l4Jus27 MGI:3577469 34 71 0 p < 0.001
l4Jus28 MGI:3577470 30 65 0 p < 0.001
l4Jus29 MGI:3577471 24 40 2 p < 0.001
l4Jus30 MGI:3577472 15 27 4 p < 0.04
l4Jus31 MGI:3577474 40 82 17 p < 0.002
The genotypes of progeny resulting from intercrosses between animals heterozygous for both the lethal mutation and the balancer are shown. 
Genotypes were determined at weaning by coat color, and a chi-square analysis was performed for each line to determine if the observed genotype 
ratio was statistically different from the expected Mendelian ratio.
Table 2: Complementation Analysis of Chromosome 4 (117–281) Lethal Lines
Line name l4Jus19 L4Jus22 l4Jus23 l4Jus24 l4Jus25 l4Jus26 l4Jus27 l4Jus28 l4Jus29 l4Jus30
l4Jus22 +
l4Jus23 + +
l4Jus24 + + +
l4Jus25 + + + +
l4Jus26 - + + + +
l4Jus27 + + + + + +
l4Jus28 + + + + + + +
l4Jus29 + + + + + + + +
l4Jus30 + + + + + + + + +
l4Jus31 + + + + + + + + + +
The results of complementation testing of the lethal mutants are shown. Crosses that complement are indicated by a '+' sign, and crosses that fail 
to complement are indicated with a '-' sign. The only lines that fail to complement are l4Jus19 and l4Jus26. For this cross 31 mice were examined at 
weaning, and no albino animals were observed (p < 0.001).Page 4 of 12
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order to determine the time of death of ten mutant lines
(Table 3). We were unable to determine the time of death
of one mutant line. We observed five mutant lines with
homozygotes that die between embryonic days (E) 5.5
and 8.5 (l4Jus23, l4Jus24, l4Jus26, l4Jus27, and l4Jus29).
For l4Jus23, l4Jus24 and l4Jus27, no homozygous mutants
were observed, although resorbed embryos were noted,
suggesting a time of death earlier than the stages exam-
ined (E11.5–E12.5, E7.5–E13.5, and E7.5–E12.5, respec-
tively). Homozygous mutants from l4Jus26 were smaller
than littermate controls and arrested prior to E7.5 (Fig.
2B). Presumed homozygous mutants from l4Jus29 are
dying at E7.5, but were unable to be genotyped due to lack
of embryonic tissue. Histological sections of these pre-
sumed l4Jus29 embryos at E6.5 revealed that the embryos
induce the formation of a maternal decidua but fail to
grow after implantation, and must die prior to gastrula-
tion (Fig. 2A).
We observed four mutants that exhibited lethality during
the E9.5–E12.5 developmental time period (l4Jus19,
l4Jus25, l4Jus28, and l4Jus30). L4Jus19 homozygous
mutants are smaller, dead, and necrotic by E12.5.
Homozygous mutants from l4Jus25 displayed arrested
development and cardiovascular defects, including peri-
cardial edema, at E10.5 (Fig. 2C). Homozygous mutants
from l4Jus28 are lethal at E10.5. This was evident in some
of the mutants that were smaller or had not turned at this
time point, and had head, cardiac and vascular defects.
Additional embryo dissections at E9.5, revealed very
abnormal allantoids, and their failure to fuse with the
chorion to establish the maternal-fetal circulation, which
is likely to result in embryonic death (Fig. 2D). Mutants
homozygous for l4Jus30 were often smaller than their lit-
termates and displayed abnormal growth and telen-
cephalon development at E11.5 (Fig. 2E).
Only one of the eleven lethal mutant lines, l4Jus31, exhib-
ited postnatal lethality. Several homozygous mutants
were observed at 2 – 4 weeks after birth. Mutants did not
appear to differ in size from wild-type littermates at or
before birth. However, mutants are significantly smaller
than their littermates (Student's t-test p < 0.001, Fig. 3) by
P14 and exhibited neurological defects, including hyper-
activity, ataxia and seizure (Additional file 1). L4Jus31
homozygous mutants never survived to sexual maturity.
We conducted complete blood counts (CBCs) to deter-
mine if homozygous mutants displayed any blood defects
but found no significant differences compared to control
littermates (data not shown).
It is likely that the majority of the mutations in our eleven
lethal lines do not lie in genes that have been previously
Table 3: Determining the Time of Death of Chromosome 4 (117–281) Lethal Mutants
Line Name # Litters 
examined
Stages 
examined
# 
Homozygous 
mutantsa
# 
Heterozygous 
mutants or 
balancer 
monozygotes
# Resorbed 
embryos
Unable to 
determineb
Stage of 
death
Notes on 
mutants
l4Jus19 1 E12.5 2 2 8 0 E9.5–12.5 Dead at E12.5
l4Jus22 1 E11.5 0 7 1 0 Not 
determined
l4Jus23 4 E11.5–12.5 0 21 16 0 Before E11.5
l4Jus24 6 E7.5–13.5 0 23 11 1 Before E7.5
l4Jus25 3 E10.5, E12.5 3 17 7 0 E9.5–12.5 Smaller, 
cardiac 
defects
l4Jus26 6 E8.5–12.5 5 30 15 1 E5.5–7.5 Smaller, 
developmental 
delay
l4Jus27 8 E7.5–12.5 0 38 5 4 Before E8.5
l4Jus28 15 E8.5–10.5, 
E12.5
25 89 3 0 E9.5–12.5 Vascular 
defects
l4Jus29 2 E8.5, E12.5 3 11 2 0 Before E7.5 Fail to grow 
after 
implantation
l4Jus30 7 E10.5–12.5 16 45 5 0 E9.5–12.5 Craniofacial 
defects
l4Jus31 8 E9.5, E12.5, 
P11–25
15 36 6 0 Post-natal Neurological 
defects
a After E12.5 mutant embryos were identified by lack of eye pigment and heterozygous mutants or balancer homozygotes were identified by eye 
pigmentation
b Embryos were lost during the dissectionPage 5 of 12
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Chromosome 4 (117–281) Lethal MutantsFigure 2
Chromosome 4 (117–281) Lethal Mutants. Mutant embryos are pictured on the right and littermate controls are pic-
tured on the left. All of the images of mutants and control from the same line were taken at the same magnification except D 
in which the mutant was photographed at a higher magnification in order to better visualize the allantois. A. Hematoxylin and 
Eosin stained sections of a presumed l4Jus29 homozygous mutant (right) and control littermate (left) are pictured at E7.5. The 
mutants die prior to gastrulation. Because of lack of embryonic tissue, these mutants were not genotyped but were identified 
by abnormal histology. B. l4Jus26 at E8.5. Mutants are smaller than control littermates and exhibit developmental delay. C. 
l4Jus25 at E10.5. Mutants display cardiovascular defects and are smaller than control littermates. Pericardial edema is evident in 
the mutant and is indicated with a white arrow. D. l4Jus28 at E9.5. Mutant embryos have not turned and the allantois grows but 
does not fuse with the chorion, shown with a white arrow. E. l4Jus30 at E11.5. Mutant embryos are smaller than control litter-
mates and exhibit growth defects, as well as abnormal telencephalon development.
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region have published knockouts with lethality before
three weeks of age [7-42]. However, by comparing the
phenotypes, two candidate genes emerged (Table 4). In
both the knockout of T-cell acute lymphocytic leukemia 1
(Tal1) and l4Jus25, mutant embryos are smaller than
expected and display pericardial edema [9], making Tal1 a
candidate for l4Jus25. One interesting candidate gene for
l4Jus31 is Disabled homolog 1 (Dab1). The l4Jus31 mutant
is very similar to the knockout mouse in that both display
postnatal lethality after a few weeks of birth and have neu-
rological defects, including ataxia [10,11]. We designed
primers that would amplify all of the coding exons as well
as the exon-intron boundaries of both genes and
sequenced Tal1 in l4Jus25, and Dab1 in l4Jus31 (Addi-
tional File 2). However, we were unable to detect any
mutations in the coding regions of either gene. This sug-
gests that these lines contain lesions in other genes in the
region, or represent new alleles of genes previously
knocked out. It does not rule out the possibility that these
mutations lie in regulatory regions for these genes.
Discussion
The eleven novel lethal lines isolated in the 4 (117–281)
screen represent a diverse group of phenotypes, which can
be used as a resource for the biomedical community to
investigate developmental processes. Our results suggest
that the majority of the mutations isolated are likely in
genes that have not been previously targeted by mutation,
or are novel alleles of previously characterized genes.
Only two mutants (l4Jus25 and l4Jus31) showed pheno-
types similar to known knockouts, but we could not
detect a molecular lesion in either candidate gene. The
chromosome 4 mutations may be valuable models for
human birth defects or neurological disease.
Here we have implicated additional loci in development
which may otherwise go undiscovered, because ENU
mutagenesis using a balancer is without bias towards a
particular abnormality or time of death. Targeting a partic-
ular region of the genome using a balancer chromosome
as described here provides an advantage over genome-
wide mutagenesis followed by rapid mapping using single
nucleotide polymorphism (SNP) arrays. Using a balancer,
lethal mutations can be identified quickly by the lack of
albino animals seen at weaning, the lethal lines are imme-
diately mapped upon isolation to the balancer region, and
then they can be easily maintained because they are not
lost by recombination and can be followed by coat color.
By screening only 530 families or pedigrees for mutation,
the 4 (117–281) screen is not meant to approach satura-
tion, but instead, provides a sampling of gene function in
a region. In the mouse, each three generation pedigree
takes approximately nine months to breed, and 530 pedi-
grees represents nearly 16,000 mice. Thus, the numbers of
families that can be examined for mutation are limited by
cost and time. However, we expected to isolate more than
11 mutant lines in this limited screen, because of our
extensive experience in using balancers productively for
ENU screens. Previously, we carried out a screen of
another portion of chromosome 4 distal to the 4 (117–
281) region described in the current report, which is
located between D4Mit281 to D4Mit51 (referred to as 4
(281–51); Fig 1A). In the 4 (281–51) screen, a total of 23
mutant lines were isolated, even though a similar number
of pedigrees were examined (551; Table 5). Nineteen lines
were homozygous lethal, two lines had growth defects
(gro69 and gro81), one had neurological defects (nur61),
and one had eye defects (eye02) [4]. The difference in the
numbers of mutations isolated in these two screens is sta-
tistically significant (Table 5, p < 0.05), using a Chi Square
test for homogeneity of samples. This test compares num-
bers drawn from a binomial distribution (mutant or not
mutant), which are sampled from more than two popula-
tions and may fall into multiple classes (mutant pheno-
types). We also compared the numbers of mutants
l4Jus31 mutants are smaller than control littermatesFigure 3
l4Jus31 mutants are smaller than control littermates. 
A. The homozygous mutant is confirmed by the white coat 
color and is pictured on the right. The heterozygous litter-
mate, with a light brown coat color, is pictured on the left. 
The picture was taken at postnatal day 28. B. l4Jus31 
homozygous mutants are significantly smaller than their con-
trol littermates at P14 (Student's t-test, n = 5 mutants, 4 con-
trol animals, p < 0.001).
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against a third screen carried out on mouse chromosome
11. In the mutagenesis screen using In(Trp53-Wnt3)8Brd
on chromosome 11, 59 lethal mutations and 32 muta-
tions that produced other phenotypes for a total of 91
mutations were isolated in 785 pedigrees screened [5].
The chromosome 11 Trp53-Wnt3 interval is predicted to
contain 905 genes, chromosome 4 D4Mit117–D4Mit281
is predicted to contain 470 genes and the D4Mit281–
D4Mit51 interval 461 (Table 5). The homogeneity of sam-
ples test shows that we isolated significantly more
mutants in the chromosome 11 screen than in either of
Table 4: Previously published knockout alleles in the chromosome 4 (117–281) balancer
Gene Published phenotype
Pre-implantation
Cdca8
Cdc20
Faf1
embryos present at E3.5 but fail to form fully expanded blastocyst [8]
embryos arrested at the two cell stage [39]
embryos arrested at the two cell stage [12]
Nasp at E3.5, blastocyts are smaller with fewer cells [13]
E5.5–E8.5
Foxd3 failure to gastrulate, finger-like extensions seen at distal tip [14]
Gjb3 lethality before somite formation [15,16]
Hdac1 embryonic lethality before turning of embryo, growth retarded after E7.5 [17,18]
Macf1 lethality before somite formation [19]
Ncdn resorption was evident prior to E6.5 [20]
Urod lethality before somite formation, no fetuses at E7.5–E9.5 [21]
E9.5–E12.5
Bmp8b smaller than expected, delayed, die by E9.25 [22]
Ppap2b abnormal gastrulation, dead by E10.5 [23,24]
Slc2a1 prenatal lethality E10–E14, reduced embryo size, overall developmental delay [25]
Stil lethality around E10.5, abnormal left-right axis patterning, growth retardation abnormal neural tube morphology and development [26]
Tal1 lethality at E8.5–E10.5, arrested development, cardiovascular defects, defects in
hematopoiesis, distended pericardial sacs, pale and necrotic [9]
E13.5–E18.5
Dhcr24 some die before birth, others smaller with less adipose tissue, decreased cholesterol levels, male and female infertility [27]
Gjb5 death at E11.5–E14.5, smaller with placental defects [28]
Marcksl1 neural tube [29]
Mtf1 embryos die around E14 due to liver degeneration [30]
Ssbp3 prenatal lethality, abnormal head development [31]
Tie1 death before E13.5, respiratory, cardiovascular, skin defects [32]
Ybx1 lethality E13.5-just after birth, reduced embryo size, craniofacial defects, abnormal neural tube closure [33]
Peri-natal
Jak1 neonates smaller with abnormal B and T cell development [34]
Khdrbs1 2/3 die at birth, and the survivors live well into adulthood [35]
Nfia lethality at P0, survivors have severe brain abnormalities [36]
Pou3f1 die within a few hours of birth due to respiratory defects [37]
Ror1 die just after birth with abnormal blood chemistry and respiratory system defects [38]
Slc6a9 die just after birth with severe motor and respiratory defects[40]
Post-natal
Dab1 lethality at 20–30 days, decreased leptin levels, nervous system defects including ataxia, abnormal brain morphology [10,11]
Dmbx1 lethality before P9, smaller, little or no milk in stomachs [7,41,42]Page 8 of 12
(page number not for citation purposes)
BMC Genetics 2009, 10:12 http://www.biomedcentral.com/1471-2156/10/12the two chromosome 4 screens. This difference cannot be
accounted for by gene density alone. It is possible that
more gene families are present on chromosome 4 than on
chromosome 11, making genes in the 4 (117–281) region
functionally redundant. However, a Pfam database survey
reveals that about 50% of the genes in each of the three
regions belong to gene families. Another possibility is that
many of the ENU induced mutations on chromosome 4
were not detrimental or had very subtle phenotypes
missed in the original screening process. Our phenotype
survey was focused on developmental defects, so it was
not comprehensive. The poor mutation recovery might
indicate that the D4Mit117-D4Mit281 region contains
genes that require a challenge or stress, such as bacterial or
viral infection, for their function to be revealed. There is
precedence for such a requirement on chromosome 4. Just
proximal to D4Mit117, the lipopolysaccharide (LPS) gene
causes no phenotype when deleted unless the mice are
challenged with a bacterial infection, in which case they
die [43]. Finally, genetic background may play a role in
the observation of phenotypes. The chromosome 11
screen was carried out on a mixed background of C57BL/
6J and 129S6/SvEvTac. However, the screens on chromo-
some 4 were carried out on a predominantly C57BL/Brd
Tyr-/- background, making the possibility of phenotype
suppression in a mixed background less likely. A control
for the mutagenesis treatment and for the phenotype
screening methods is the cohort of mutations that
mapped to other chromosomes. Of note, a similar
number of mutations that segregated genome-wide were
isolated in each of these screens (Table 5; http://
www.mouse-genome.bcm.tmc.edu). These mutations
had a wide variety of phenotypes, but none were lethal,
because we did not wish to recover lethal mutations seg-
regating genome-wide.
Conclusion
We have already shown that mouse chromosome 11 is
unique because it contains a high number of essential
genes, and we have suggested that genes with similar func-
tions may be clustered in the genome [44]. Such an idea is
not novel, since essential genes are clustered in other
organisms, including C. elegans and Drosophila [45]. After
screening 530 families for the chromosome 4 (117–281)
region, it became obvious that ours was not a productive
screen for functionally annotating this region with devel-
opmental phenotypes. We would therefore not recom-
mend screening additional families for mutations in the 4
Table 5: Comparison of Chromosome 4 and 11 ENU Balancer Screens
Parameter Chr 4
(117–281)
Chr 4
(281–51)
Chr 11
(Trp53-Wnt3)
Interval Breakpoints 96.4–129.8 Mb 129.8–154.4 Mb 69.4–103.7 Mb
Interval size 33 Mb 25 Mb 34 Mb
Number of annotated genes 470 461 905
Pedigrees screened 530 551 785
Lethal lines 11 19 59
Other viable phenotypes 0 4 32
Total mutations 11 23 91
Mutations/Mb 0.33 0.92 2.68
Homogeneity of samplesa 3.913, p < 0.05 22.8, p < 0.001 37.2, p < 0.001
Frequency of mutations mapping outside of the balancer region 1 in 5.4 1 in 4.8 1 in 4.2
Literature Reference This report Hentges et al. 2006 [4] Kile et al. 2003 [5]
In all cases, the phenotype screen included a coat color screen for all lethals in the balancer region. It also included a complete blood count for all 
blood cell parameters, a screen for neutral cholesterols using tandem mass spectrometry, a urine screen for albumin and glucose, and a general 
visual assessment of skin, coat, eyes, fur, movement and balance, as well as morphology on all viable mice, which would carry mutations segregating 
to the balancer region or elsewhere in the genome.
a A Chi square test for homogeneity of samples in a binomial distribution with one degree of freedom. The values represent the significance from 
the numbers of mutations isolated in the next column, with the exception that the number in column c is the difference from column a.Page 9 of 12
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phenotypes listed in materials and methods. Instead,
alternative phenotype assays may uncover the functions
of genes in this region. Ultimately, once the genes respon-
sible for the mutant phenotypes are found, we will have a
greater understanding of gene function on mouse chro-
mosome 4 and will have the tools necessary for under-
standing human diseases that map to human
chromosome 1.
Methods
Mutagenesis Screen
The balancer chromosome B6-Brd.In(D4Mit117;D4Mit2
81)1Brd or In4(1)Brd was used to isolate recessive muta-
tions in a three generation screen after ENU treatment of
B6-albino males. The coat color scheme for carrying out
mutagenesis and the balancer mice have been previously
described [2,4]. Five hundred and thirty pedigrees were
screened and eleven lethal lines were isolated. All experi-
ments involving animals had ethical approval from the
Institutional Animal Care and Use Committee (IACUC)
of Baylor College of Medicine. The balancer chromosome
was created and maintained on the on the C57BL/6-Tyrc-
Brd albino strain background by intercrosses.
The phenotype screen included a coat color screen for all
lethals in the balancer region. It also included a complete
blood count for all blood cell parameters using a Cell-Dyn
3500R (Abbott Laboratory), a screen for neutral cholester-
ols using tandem mass spectrometry, a urine screen for
albumin and glucose (Chemstrip9 from Roche), and a
general visual assessment of skin, coat, eyes, fur, move-
ment and balance, as well as morphology on all viable
mice, which would carry mutations segregating to the bal-
ancer region or elsewhere in the genome.
Sequence comparisons
Genomic sequences of mouse and human were down-
loaded from Ensembl v.49 http://www.ensembl.org. Each
region of mouse sequences was divided into 150-kb frag-
ments, which were then blasted using Megablast http://
www.ncbi.nlm.nih.gov/BLAST/download.shtml. The
sequence comparison was carried out on a Sun cluster
with SunFire 280R http://www.sun.com. Mouse genomic
annotation was downloaded from Ensembl BioMart v.49
http://www.ensembl.org/Mus_musculus/Info/Index. To
visualize the blast results, we developed in-house software
written in Microsoft Active Server Page http://www.micro
soft.com. All blast results were uploaded in a MS SQL
server database, and the results displayed on a PC.
Complementation Analysis
Mice that were heterozygous for both the lethal mutations
and chromosome In4(1)Brd balancer were bred together. If
albino mice were observed at weaning, the two lines com-
plemented. If no albino mice in a cohort of more than 30
were found at weaning, the lines failed to complement.
Embryo dissection and analysis
For each mutant line, timed matings were carried out on
heterozygous animals. Mating cages consisting of one
male and two females were set up in the evenings and
females were observed for a vaginal plug for five consecu-
tive mornings. The day that a vaginal plug was observed
was considered to be E0.5.
Initial embryo dissections were performed on E12.5 and
then earlier or later, depending on the findings. All
embryos that were obtained from dissections were geno-
typed, and many were photographed with a Leica micro-
scope from Diagnostic Instruments or a Zeiss microscope.
Genotyping on embryos before E12.5 was performed by
PCR using DNA prepared by incubating yolk sacs or
whole embryos with 50 mM NaOH at 95°C for 20 min-
utes, followed by neutralization with 1/5 volume of 0.5 M
Tris, pH 8.0. The PCR conditions were: 1× Invitrogen PCR
buffer, 1.5 mM MgCl2, 0.3 mM dNTPs, 0.5 μM D4Mit12
(GCTTGCTTTAGGAGTGTGCC and TATTTGCTCTCCATT-
TCCCC) or D4Mit332 (TCAATCCCATTGGCTATATATGC
and TGAGAAACCTCTCCAGCACC) primer mix, 250 ng
template, 0.25 U Taq Polymerase (Invitrogen, Carlsbad,
CA). Cycling conditions were: 94°C 5 min; 40 cycles of
94°C 45 sec; 58°C 45 sec; 72°C 45 sec; then 7 min at
72°C; followed by incubation at 4°C. After E12.5,
embryos could be genotyped visually by the presence or
absence of eye pigment.
Histology
Decidua or embryos were dissected at E6.5–E12.5, fixed
for 3 hours in Bouin's fixative or overnight in 4% PFA, and
then dehydrated with series of ethanol washes and
embedded in paraffin. The embryos were sectioned at 5–
7 μm, staining with Hematoxylin and Eosin, and analyzed
with a Zeiss Axioplan light microscope.
Comparison of ENU-mutants with previously published 
knockouts
Mouse Genome Informatics was used to find candidate
genes for the 11 novel ENU-mutants on chromosome 4
between 96–130 Mb. The Phenotypes, Alleles and Disease
Models database was searched in this region for published
knockouts http://www.informatics.jax.org/pheno
types.shtml. Ninety-seven of the 470 genes in the region
have been targeted by gene trap or knockout constructs. In
searching for knockouts that were lethal, we excluded
genes that were lethal after three weeks of age, or if there
was a double or triple knockout required for lethality.
Using this method, we found 30 alleles that are
homozygous lethal before weaning and thus are potential
candidate genes in the region. The phenotypes of thesePage 10 of 12
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lethal lines have been summarized in Supplemental Table
1.
Sequencing
Coding exons of Tal1 and Dab1 were identified using
Ensembl v50 and primers were designed to flank each
exon by 100–150 bp (Additional file 2). Genomic DNA
from l4Jus25 and l4Jus31 was phenol-chloroform
extracted from frozen livers. PCR amplicons were either
shipped to Agencourt Bioscience Corporation (Beverly,
MA) for single pass sequencing with both forward and
reverse PCR primers or were sequenced directly using
BigDye Terminator v3.1 (Applied Biosystems) according
to the manufacturer's instructions. The sequencing chro-
matograms were analyzed using Sequencher 4.7 (Ann
Arbor, MI).
Protein Family Analysis
The protein family data are based on Pfam annotated
databases. The most current Pfam is version 23.0 [46].
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